Literature DB >> 9028868

One-electron reduction of chromium(VI) by alpha-lipoic acid and related hydroxyl radical generation, dG hydroxylation and nuclear transcription factor-kappaB activation.

F Chen1, J Ye, X Zhang, Y Rojanasakul, X Shi.   

Abstract

Reaction of chromium(VI) with alpha-lipoic acid (reduced form, also called 1,2-dithiolane-3-pentanoic acid) generated Cr(V) and hydroxyl radical (*OH) as measured by electron spin resonance and ESR spin trapping. 5,5-Dimethyl-1-pyrroline was used as a spin trapping agent. Catalase inhibited the *OH generation and enhanced the Cr(V) formation. Superoxide dismutase had an opposite effect. H2O2 enhanced the *OH generation and decreased the Cr(V) formation in a dose-dependent manner. Metal chelators, EDTA, diethylenetriaminepentaacetic acid, deferoxamine, and 1, 10-phenanthroline inhibited *OH radical generation in the order of EDTA > 1,10-phenanthroline > DTPA > deferoxamine. Oxygen consumption measurements indicated that molecular oxygen was used to generate *OH radical in the mixture of Cr(VI) and alpha-lipoic acid. H2O2 and superoxide radical (O2-) were involved as reactive intermediates. The *OH radical was generated via Cr(V)-mediated Fenton-like reaction (Cr(V) + H2O2 --> Cr(VI) + OH- + *OH). HPLC measurements show that the *OH radical generated by this reaction is capable of generating 8-hydroxyl-2'-deoxyguanosine from 2-deoxyguanosine. Incubation of Cr(VI) with cultured Jurkat cells resulted in an activation of DNA binding activity of the nuclear factor (NF)-kappaB. Addition of alpha-lipoic acid enhanced the NF-kappaB activation, while the *OH radical scavenger, sodium formate, inhibited it, showing that alpha-lipoic acid enhanced Cr(VI)-induced NF-kappaB activation via free radical reactions. The results indicate that while alpha-lipoic acid is considered to be an antioxidant, it may be a cellular one-electron Cr(VI) reductant and could be involved in the mechanism of Cr(VI)-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9028868     DOI: 10.1006/abbi.1996.9849

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Chromium disrupts chromatin organization and CTCF access to its cognate sites in promoters of differentially expressed genes.

Authors:  Andrew VonHandorf; Francisco Javier Sánchez-Martín; Jacek Biesiada; Hongxia Zhang; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2018-05-03       Impact factor: 4.528

2.  Chromium (VI) inhibits heme oxygenase-1 expression in vivo and in arsenic-exposed human airway epithelial cells.

Authors:  Kimberley A O'Hara; Antonia A Nemec; Jawed Alam; Linda R Klei; Brooke T Mossman; Aaron Barchowsky
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

3.  Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

Authors:  Yunxia Fan; Jerald L Ovesen; Alvaro Puga
Journal:  J Trace Elem Med Biol       Date:  2012-05-19       Impact factor: 3.849

Review 4.  The effects of chromium(VI) on the thioredoxin system: implications for redox regulation.

Authors:  Charles R Myers
Journal:  Free Radic Biol Med       Date:  2012-04-18       Impact factor: 7.376

5.  Reduction of hexavalent chromium by human cytochrome b5: generation of hydroxyl radical and superoxide.

Authors:  Griselda R Borthiry; William E Antholine; B Kalyanaraman; Judith M Myers; Charles R Myers
Journal:  Free Radic Biol Med       Date:  2006-12-15       Impact factor: 7.376

6.  Combining Drosophila melanogaster somatic-mutation-recombination and electron-spin-resonance-spectroscopy data to interpret epidemiologic observations on chromium carcinogenicity.

Authors:  A J Katz; A Chiu; J Beaubier; X Shi
Journal:  Mol Cell Biochem       Date:  2001-06       Impact factor: 3.396

Review 7.  Molecular mechanisms of Cr(VI)-induced carcinogenesis.

Authors:  Min Ding; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

Review 8.  Genetic and cellular mechanisms in chromium and nickel carcinogenesis considering epidemiologic findings.

Authors:  Arthur Chiu; A J Katz; Jefferson Beaubier; Nancy Chiu; Xianglin Shi
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

9.  Hexavalent chromium promotes differential binding of CTCF to its cognate sites in Euchromatin.

Authors:  Andrew VonHandorf; Hesbon A Zablon; Jacek Biesiada; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.